Risperdal/Gynecomastia Trial Stopped; Defense Must Produce Study Reanalysis Data
PHILADELPHIA — A Pennsylvania state court Risperdal gynecomastia trial was stopped Nov. 18 to allow defendants Janssen Pharmaceuticals Inc. and Johnson & Johnson time to give the plaintiff data about a...To view the full article, register now.
Already a subscriber? Click here to view full article